Brown AS, Schaefer CA, Quesenberry Jr. CP, et al. Maternal Exposure to Toxoplasmosis and Risk of Schizophrenia in Adult Offspring. Am J Psychiatry 2005; 162:767-773.
Coyle JT, Tsai G. The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology 2004;174(1):32-8.
Dakhale GN, Khanzode SD, Khanzode SS, Saoji A. Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia. Psychopharmacology 2005;182(4):494-8.
Dohan FC, Gasberger JC. Relapsed schizophrenics. Earlier discharge from the hospital after cereal-free, milk-free diet. Am J Psychiatry 1973;130:685-688.
Dohan FC, Harper EH, Clark MH, et al. Is schizophrenia rare if grain is rare? Biol Psychiatry 1984;19:385-399.
Herrán A, Garcia-Unzueta MT, Amado JA, et al. Folate levels in psychiatric outpatients. Psychiatry Clin Neurosci. 1999;53(4):531-3.
Hoffer A, Osmond H. The adrenochrome hypothesis and psychiatry. Journal of Orthomolecular Medicine 1990;(1):32-45.
Insel BJ, Schaefer CA, McKeague IW, et al. Maternal iron deficiency and the risk of schizophrenia in offspring. Arch Gen Psychiatry 2008;65(10):1136-44.
Javitt DC, Silipo G, Cienfuegos A, et al. Adjunctive high-dose glycine in the treatment of schizophrenia. Int J Neuropsychopharmacol 2001;4(4):385-91.
Javitt DC. Glycine modulators in schizophrenia. Curr Opin Investig Drugs 2002;3(7):1067-72.
Kalaydjian AE, Eaton W, Cascella N, Fasano A. The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr Scand 2005: 1–9.
Khashan AS, Abel KM, McNamee R, et al. Higher Risk of Offspring Schizophrenia Following Antenatal Maternal Exposure to Severe Adverse Life Events. Arch Gen Psychiatry. 2008;65(2):146-152.
Lerner V, Miodownik C, Kaptsan A, et al. Vitamin B(6) in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study. Am J Psychiatry 2001;158(9):1511-4.
Mascord I, Freed D. Antibodies to foodstuffs in schizophrenics. Letter. Br Med J. 1978;1(6123): 1351.
Messamore E, Hoffman WF, Janowsky Aa. The niacin skin flush abnormality in schizophrenia: a quantitative dose–response study. Schizophrenia Research 2003;62(3):251-58.
Mulholland C, Cooper S. The symptom of depression in schizophrenia and its management. Advances in Psychiatric Treatment 2000;6:169-177.
Peet M, Stokes C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs 2005;65(8):1051-9.
Singh MM, Kay SR. Wheat gluten as a pathogenic factor in schizophrenia. Science 1976;191:401-2.
